0001179110-14-008321.txt : 20140513
0001179110-14-008321.hdr.sgml : 20140513
20140513172253
ACCESSION NUMBER: 0001179110-14-008321
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140513
FILED AS OF DATE: 20140513
DATE AS OF CHANGE: 20140513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MERCER ROAD
CITY: NATICK
STATE: MA
ZIP: 01760
BUSINESS PHONE: 508-975-4820
MAIL ADDRESS:
STREET 1: 2 MERCER ROAD
CITY: NATICK
STATE: MA
ZIP: 01760
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Primiano Christopher Brett
CENTRAL INDEX KEY: 0001603510
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 14838462
MAIL ADDRESS:
STREET 1: 217 WEST CANTON STREET, APARTMENT 3
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
edgar.xml
FORM 4 -
X0306
4
2014-05-13
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001603510
Primiano Christopher Brett
C/O KARYOPHARM THERAPEUTICS INC.,
2 MERCER ROAD
NATICK
MA
01760
0
1
0
0
VP, GEN COUNSEL & SECRETARY
Common Stock
2014-05-13
4
P
0
1000
26.75
A
1000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.4999 to $27.00, inclusive. The reporting person undertakes to provide to Karyopharm Therapeutics Inc., any security holder of Karyopharm Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
/s/ Christopher B. Primiano
2014-05-13